-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on DexCom, Raises Price Target to $87

Benzinga·07/16/2026 15:51:08
语音播报
Truist Securities analyst Richard Newitter maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $80 to $87.